Todd Tucker
Oral and Maxillofacial Surgery · Eugene, ORNPI 1619981859
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Straumann USA LLC accounts for 86.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,459 and has fallen 84.8% since, to $221 in 2025.
Across 45 payments — averaging $52.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$2K
- Biohorizons Implant Systems Inc.$102
- Nobel Biocare USA$78
- Stryker$50
- Southern Anesthesia & Surgical, Inc (dba ACE Southern)$33
- ACE Surgical Supply Co., Inc.$20
- plus $27 from 2 others
What the payments were for
- Travel & lodging$83135%
- Food & beverage$1,23152%
- Education$1506%
- Gifts$1346%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 32 | $2,038 |
| Biohorizons Implant Systems Inc. | 4 | $102 |
| Nobel Biocare USA | 2 | $78 |
| Stryker | 1 | $50 |
| Southern Anesthesia & Surgical, Inc (dba ACE Southern) | 1 | $33 |
| ACE Surgical Supply Co., Inc. | 3 | $20 |
| Zimmer Biomet | 1 | $16 |
| Zest Holdings, LLC | 1 | $11 |
How this compares
$2,346 in reported general payments places this provider in the 70th percentile of 93 oral and maxillofacial surgery providers in Oregon.
See all oral and maxillofacial surgery providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 556 | $2,676 |
| Cephalexin | 297 | $2,643 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 400 | $1,301 |
| Clindamycin Hcl | 51 | $406 |
| CefuroximeCefuroxime Axetil | 11 | $161 |
| Oxycodone Hcl | 19 | $146 |
| Amoxicillin | 25 | $113 |
| Tramadol Hcl | 32 | $94 |
| Lorazepam | 14 | $7 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Eugene
- Tyler ClarkEugene$7K
- Bryan WilliamsEugene$6K
- Timothy WelchEugene$2K
- Thomas JacksEugene$1K
- Richard BellPortland$156K
- Peter DennisLake Oswego$151K
- Baber KhatibPortland$107K
- Jay MalmquistPortland$86K
- Ashish PatelPortland$55K
- Mark EngelstadPortland$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.